Provided by Tiger Trade Technology Pte. Ltd.

Medpace

428.03
+11.992.88%
Post-market: 428.030.00000.00%18:01 EST
Volume:729.19K
Turnover:313.95M
Market Cap:12.15B
PE:28.01
High:442.41
Open:421.45
Low:421.45
Close:416.04
52wk High:628.92
52wk Low:250.05
Shares:28.38M
Float Shares:22.22M
Volume Ratio:0.92
T/O Rate:3.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.28
EPS(LYR):15.28
ROE:70.23%
ROA:16.40%
PB:26.46
PE(LYR):28.01

Loading ...

Pinterest, DraftKings, And Flutter Are Among Top 10 Large Cap Losers Last Week (Feb. 9-Feb. 13): Are the Others in Your Portfolio?

Benzinga_recent_news
·
Yesterday

Medpace Holdings Raised to Buy From Hold by Jefferies

Dow Jones
·
Feb 14

Medpace Shares Rise After Jefferies Upgrade

MT Newswires Live
·
Feb 14

Stock Track | Medpace Soars 5.08% Intraday After Jefferies Upgrade to Buy

Stock Track
·
Feb 13

Jefferies Upgrades Medpace to Buy From Hold, $560 Price Target

MT Newswires Live
·
Feb 13

Medpace upgraded to Buy from Hold at Jefferies

TIPRANKS
·
Feb 13

Medpace Holdings Inc : Jefferies Raises to Buy From Hold

THOMSON REUTERS
·
Feb 13

Why this drug-research company's stock is having its worst day since 1999

Dow Jones
·
Feb 13

Assessing Medpace Holdings (MEDP) Valuation After Recent Share Price Pullback

Simply Wall St.
·
Feb 12

Stock Track | Medpace Plummets 5.04% Intraday Amid Multiple Analyst Price Target Cuts

Stock Track
·
Feb 12

Truist Securities Adjusts Price Target on Medpace to $539 From $555, Maintains Hold Rating

MT Newswires Live
·
Feb 11

Medpace price target lowered to $539 from $555 at Truist

TIPRANKS
·
Feb 11

Medpace Holdings Is Maintained at Market Perform by Leerink Partners

Dow Jones
·
Feb 11

Medpace Holdings Inc : Bmo Cuts Target Price to $460 From $600

THOMSON REUTERS
·
Feb 11

Medpace Holdings Inc : Barclays Cuts Target Price to $500 From $525

THOMSON REUTERS
·
Feb 11

U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart

Reuters
·
Feb 11

Zelluna Announces Clinical Partnership With Medpace

Reuters
·
Feb 11

Zelluna Selects Medpace to Run First Clinical Trial for ZIMA-101

Reuters
·
Feb 11

Medpace Holdings’ Earnings Call Signals Growth Amid Volatility

TIPRANKS
·
Feb 11

Medpace upgraded to Outperform from Neutral at Baird

TIPRANKS
·
Feb 11